BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 2203139)

  • 1. [The pathogenesis of multiple sclerosis].
    Kesselring J
    Schweiz Med Wochenschr; 1990 Jul; 120(30):1083-90. PubMed ID: 2203139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of neurosteroids on the pathogenesis of multiple sclerosis.
    Leitner H
    Med Hypotheses; 2010 Aug; 75(2):229-34. PubMed ID: 20227191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of tissue damage in multiple sclerosis by nuclear magnetic resonance.
    Barkhof F; van Walderveen M
    Philos Trans R Soc Lond B Biol Sci; 1999 Oct; 354(1390):1675-86. PubMed ID: 10603619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Demyelination, inflammation, and neurodegeneration in multiple sclerosis deep gray matter.
    Vercellino M; Masera S; Lorenzatti M; Condello C; Merola A; Mattioda A; Tribolo A; Capello E; Mancardi GL; Mutani R; Giordana MT; Cavalla P
    J Neuropathol Exp Neurol; 2009 May; 68(5):489-502. PubMed ID: 19525897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pathologic substrate of magnetic resonance alterations in multiple sclerosis.
    Lassmann H
    Neuroimaging Clin N Am; 2008 Nov; 18(4):563-76, ix. PubMed ID: 19068402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of blood-brain barrier disruption on glial cell function in multiple sclerosis.
    McQuaid S; Cunnea P; McMahon J; Fitzgerald U
    Biochem Soc Trans; 2009 Feb; 37(Pt 1):329-31. PubMed ID: 19143657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cortical demyelination and diffuse white matter injury in multiple sclerosis.
    Kutzelnigg A; Lucchinetti CF; Stadelmann C; Brück W; Rauschka H; Bergmann M; Schmidbauer M; Parisi JE; Lassmann H
    Brain; 2005 Nov; 128(Pt 11):2705-12. PubMed ID: 16230320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Use of magnetic resonance imaging in the diagnosis and prognosis of multiple sclerosis].
    Zivadinov R; Sepcić J
    Lijec Vjesn; 2006; 128(9-10):295-308. PubMed ID: 17128669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meningeal inflammation is not associated with cortical demyelination in chronic multiple sclerosis.
    Kooi EJ; Geurts JJ; van Horssen J; Bø L; van der Valk P
    J Neuropathol Exp Neurol; 2009 Sep; 68(9):1021-8. PubMed ID: 19680141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnetic resonance techniques for the in vivo assessment of multiple sclerosis pathology: consensus report of the white matter study group.
    Filippi M; Falini A; Arnold DL; Fazekas F; Gonen O; Simon JH; Dousset V; Savoiardo M; Wolinsky JS;
    J Magn Reson Imaging; 2005 Jun; 21(6):669-75. PubMed ID: 15906322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pathology of multiple sclerosis.
    Sobel RA
    Neurol Clin; 1995 Feb; 13(1):1-21. PubMed ID: 7739499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gray and normal-appearing white matter in multiple sclerosis: an MRI perspective.
    Vrenken H; Geurts JJ
    Expert Rev Neurother; 2007 Mar; 7(3):271-9. PubMed ID: 17341175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Axonal injury in the cerebral normal-appearing white matter of patients with multiple sclerosis is related to concurrent demyelination in lesions but not to concurrent demyelination in normal-appearing white matter.
    Narayanan S; Francis SJ; Sled JG; Santos AC; Antel S; Levesque I; Brass S; Lapierre Y; Sappey-Marinier D; Pike GB; Arnold DL
    Neuroimage; 2006 Jan; 29(2):637-42. PubMed ID: 16126413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diffusely abnormal white matter in chronic multiple sclerosis: imaging and histopathologic analysis.
    Seewann A; Vrenken H; van der Valk P; Blezer EL; Knol DL; Castelijns JA; Polman CH; Pouwels PJ; Barkhof F; Geurts JJ
    Arch Neurol; 2009 May; 66(5):601-9. PubMed ID: 19433660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood-brain barrier alterations in both focal and diffuse abnormalities on postmortem MRI in multiple sclerosis.
    Vos CM; Geurts JJ; Montagne L; van Haastert ES; Bö L; van der Valk P; Barkhof F; de Vries HE
    Neurobiol Dis; 2005 Dec; 20(3):953-60. PubMed ID: 16039866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Necrotic plaque formation in a case of frontal lobe multiple sclerosis].
    Sugano M; Hirayama K; Saito T; Tsukamoto T; Yamamoto T
    Rinsho Shinkeigaku; 1992 Jun; 32(6):621-5. PubMed ID: 1424342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Value of magnetization transfer imaging in judging microchanges lesions in normal-appearing white matter of multiple sclerosis].
    Chu SG; Shen TZ; Chen XR
    Zhonghua Yi Xue Za Zhi; 2004 Jul; 84(14):1181-5. PubMed ID: 15387980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pathology of multiple sclerosis and its evolution.
    Lassmann H
    Philos Trans R Soc Lond B Biol Sci; 1999 Oct; 354(1390):1635-40. PubMed ID: 10603616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Magnetic Resonance Imaging study of the role of the blood-brain barrier in the pathogenesis of experimental allergic encephalomyelitis: application to multiple sclerosis].
    Chambron J; Namer IJ; Steibel J; Gounot D; Armspach JP
    Bull Acad Natl Med; 1994 Dec; 178(9):1647-63; discussion 1663-5. PubMed ID: 7788436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gray matter atrophy in multiple sclerosis: a longitudinal study.
    Fisher E; Lee JC; Nakamura K; Rudick RA
    Ann Neurol; 2008 Sep; 64(3):255-65. PubMed ID: 18661561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.